We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections. The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern
Researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs. University of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs. The
A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections. The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern
A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections. The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern
Two of the closest known relatives to SARS-CoV-2 -- a pair of bat coronaviruses discovered by researchers in Laos -- may transmit poorly in people despite being genetically similar to the COVID-19-causing virus, a new study reveals. The findings provide clues as to why some viruses have greater 'pandemic potential' than others and how researchers
Researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs. University of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs. The
That long COVID patients have unique inflammation patterns in their blood, suggesting the potential for targeted immune therapies. This groundbreaking research provides hope for the development of effective treatments for long COVID, offering promise for those suffering from persistent symptoms
Vaccine and Infectious Disease Organization can give you the confidence you need. This study highlights the extended immunity provided by a booster shot, offering a renewed sense of protection against COVID-19. With insights into the impact of age, sex, and comorbidities on immune response, this research provides valuable information for individuals considering a booster. Stay informed and stay protected with the latest findings from York University's Vaccine and Infectious Disease Organization
Crucial for understanding the evolution of SARS-CoV-2 and developing targeted treatments. tARC-seq's ability to capture real-time mutations sets it apart from traditional sequencing methods, making it a valuable tool in tracking viral mutations and informing public health strategies. This groundbreaking technology has the potential to revolutionize our approach to studying and combating infectious diseases
Maximize its effectiveness in reducing illness severity and transmission. With this new information, there is potential to improve treatment outcomes and slow the spread of COVID-19. Expanding access to Paxlovid globally could be a pivotal step in mitigating the impact of the virus
Symptoms, a new study finds. The study reveals that the nasal cells of young people have a stronger immune response to the virus compared to older individuals, potentially leading to less severe symptoms in children. This discovery provides crucial insights into the varying effects of COVID-19 on different age groups and could inform future research and treatment strategies. Understanding the unique immune responses in different age groups is essential for developing targeted interventions and improving public health responses to the pandemic
